Biobanking 2018


On 18 & 19 October 2018, Paris will host the BioTech Pharma Summit: Biobanking 2018. This year event will bring together the world’s leading experts in biorepositories, policy makers, and scientific actors to strengthen knowledge in biobanking as well as explore future advances in the field of biosampling for precision medicine, drug development and health research.

The biobanking market is expected to reach USD 2.69 Billion by 2022 from USD 1.72 Billion in 2016 at a CAGR of 7.8%. Learn the current market trends and future challenges only at the Biobanking 2018

Our distinguished panel includes renowned clinicians, researchers, executives and technical professionals from the biopreservation industry as well as the pioneers for a worldwide human research resource. Moreover, the current era is flooded with new advanced technologies, which culminated with the proliferation of more Biobank institutes globally, acting as a clear indicator of a market growth in the field.

Geographically, the EMEA region is estimated to account for a market share of approximately 44% during the predicted period. The presence of a well-established biobanking system in the Nordic countries, such as Sweden, Norway, Denmark, Finland, and Iceland, is a significant factor that bolsters market growth in this region. This conference will gather biobanking leaders from the north, as well as from across the Atlantic, in order to zoom in the market prospects and understand the dynamics of this fast-paced growing industry.

Over 20 presentations and case studies focusing on the key areas of the biobanking industry including market access strategies, clinical development, commercialization, biostorage and biosampling-analytics at the Biobanking 2018

The BioTech Pharma Summit: Biobanking 2018 is the leading event to get through  the biobanking’s ever-thriving market and convenes key stakeholders from the field,  and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biobanking product success. We invite all the participants across the globe to join our scientific gathering, which aims to reveal the newest data and share innovative ideas from research area of bioengeneering and tissue preservation.


  • Present different types of biobanking and innovative models in precision medicine
  • Understand the opportunities and challenges of biosampling
  • Learn the latest technological methods and procedures for biopreservation, storage stability and validation, while naming evidence-based best practices
  • Explore new sample quality management systems, quality standards and accreditation
  • Learn how to maintain a sustainable infrastructure in biobanking
  • Debate the social and ethical challenges of biobanking for human research
  • Predict the market impact of biobanking in the next decade
  • Current market trends and future challenges for biobanking success
  • Biobanking development in emerging markets
  • Prognosis for the Global Biobanking market in an era of transformative new technologies
  • Commercial challenges and opportunities
  • Redesigning the biobanking business model
  • Clinical Trial Strategies in Biobanking and Drug Development
  • Determining the right investments & potential returns from Biobanks
  • Leading Biobank companies share their views and strategies on successful market penetration and learn to implement best practices through recent successful strategies and business models
  • Real time case studies


The BioTech Pharma Summit: (EPM Group) are exclusive events designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. Chief Executives, Executive Directors, Vice Presidents, Heads and Team Leaders and Managers including:

  • Biobanking Researchers
  • Biobanking Faculty Members
  • Medical Colleges
  • Biobanking Associations and Societies
  • Training Institutes
  • Cryo storage Companies
  • Data Provacy and Management Companies
  • Security Officers
  • Global Biobanking Companies
  • Business Developers
  • Biobanking investors
  • Lab Managers
  • Biopharmaceuticals and Biologics Researchers
  • Molecular Technologies
  • Intellectual property
  • Legislation and Policy Advice
  • Legislation and Policy Advice
  • Drug and Safety Assessment
  • Market Strategy
  • Biopharmaceuticals
  • Chief Scientific Officer
  • Clinical Immunology
  • Drug Safety Assessment & Risk Management
  • Population and Disease Based biobanks
  • Bioinnovation
  • Intellectual property
  • Regulatory Affairs
  • Health Economics
  • Principal Scientists
  • Process Control and Analytical Technologies
  • Quality Affairs/ Quality Control
  • Regulatory Affairs
  • Regulatory Compliance
  • Legal Affairs
  • R & D
  • New Product Development
  • Quality Affairs/Quality Control
  • Health Economics
  • Process Control and Analytical Technologies
Christoph Brochhausen-Delius
Vice Director, Senior Consultant Pathologist at the University Medical Centre Mainz
Marybeth Joshi
Assistant Director Biobank & Translational Research Core at Duke University Medical Center
Manuel Morente
Head of the Spanish National Cancer Research Centre Biobank, and Former President of the ESBB
Chief Operating Officer at Biobank Graz, Austria
Jeffrey Goddard
Director of Global Business Development at EPL Archives, Inc.
Svetlana Gramatiuk
President and Medical Director at Ukraine Association of Biobank
Ian Pope
Global Head of Cryo Automation Solutions at Brooks Life Science Systems
Helena Pereira de Melo
Vice-Dean of Faculty of Law at the Nova University of Lisbon
Ali Ismail
Founder & Managing Director at Birka Biostorage
Research Director at INSERM; Director at BIOBANQUES Infrastructure, France
Jennifer Cheeseman-Janes, MS, Senior Director, Biobank & Translational Research Core Department of Surgery at Duke University School of Medicine, USA
Managing Director of Biothéque Wallonie Bruxelles, Belgium
Alexander Werner
Head of Application Group at ASKION Gera
Vanessa Tumilasci
Project Director at Trans‑Hit Biomarkers Inc.
Basic Package
Buy Ticket

Access to all Sessions

Access to all Networking Sessions

Cocktail Reception Included

Premium Package
Buy Ticket

Unique one-on-one meetings

Airport pick-up/drop-off

2 nights at the Hotel Venue

Basic Exhibition Package
Buy Ticket

3m2 exhibition space

1 Complementary ticket

25% discount for extra ticket

Premium Exhibition Package
Buy Ticket

6m2 exhibition space

1 Complementary ticket

2 nights at the Hotel Venue